 | • レポートコード：D0GIR-00545 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、慢性心不全（CHF）治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。慢性心不全（CHF）治療の種類別市場規模（ICD、VAD、医薬品、その他）、用途別市場規模（病院、クリニック、家庭、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Medtronic、HeartWare、Merck、Abbott、Boston Scientific Corporation、Johnson & Johnson、GlaxoSmithKline plc、New Haven Pharmaceuticals, Inc.、Stanley Pharmaceuticals、Pfizer、Symplmed Pharmaceuticals、Cardiokinetix、Novartis International AG、Jarvik Heart、Berlin Heart GmbH、Abiomed、Biovail Corporation、Biotronik、ReliantHeart, Inc.、Bristol-Myers Squibb Company ・地域別グローバル市場分析 2015年-2020年 ・慢性心不全（CHF）治療の北米市場（アメリカ、カナダ、メキシコ） ・慢性心不全（CHF）治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・慢性心不全（CHF）治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・慢性心不全（CHF）治療の南米市場（ブラジル、アルゼンチン） ・慢性心不全（CHF）治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ICD、VAD、医薬品、その他 ・用途別分析：病院、クリニック、家庭、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Chronic Heart Failure Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Chronic Heart Failure Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Chronic Heart Failure Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Chronic Heart Failure Treatment market has been segmented into:
ICDs
VADs
Drugs
Others
By Application, Chronic Heart Failure Treatment has been segmented into:
Hospital
Clinic
Household
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Chronic Heart Failure Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Chronic Heart Failure Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Chronic Heart Failure Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Chronic Heart Failure Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Chronic Heart Failure Treatment Market Share Analysis
Chronic Heart Failure Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Chronic Heart Failure Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Chronic Heart Failure Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Chronic Heart Failure Treatment are:
Medtronic
HeartWare
Merck
Abbott
Boston Scientific Corporation
Johnson & Johnson
GlaxoSmithKline plc
New Haven Pharmaceuticals, Inc.
Stanley Pharmaceuticals
Pfizer
Symplmed Pharmaceuticals
Cardiokinetix
Novartis International AG
Jarvik Heart
Berlin Heart GmbH
Abiomed
Biovail Corporation
Biotronik
ReliantHeart, Inc.
Bristol-Myers Squibb Company
Among other players domestic and global, Chronic Heart Failure Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Chronic Heart Failure Treatment Market Overview
1.1 Product Overview and Scope of Chronic Heart Failure Treatment
1.2 Classification of Chronic Heart Failure Treatment by Type
1.2.1 Global Chronic Heart Failure Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Chronic Heart Failure Treatment Revenue Market Share by Type in 2019
1.2.3 ICDs
1.2.4 VADs
1.2.5 Drugs
1.2.6 Others
1.3 Global Chronic Heart Failure Treatment Market by Application
1.3.1 Overview: Global Chronic Heart Failure Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Global Chronic Heart Failure Treatment Market by Regions
1.4.1 Global Chronic Heart Failure Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Chronic Heart Failure Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Chronic Heart Failure Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Chronic Heart Failure Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chronic Heart Failure Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Chronic Heart Failure Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chronic Heart Failure Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic SWOT Analysis
2.1.4 Medtronic Product and Services
2.1.5 Medtronic Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 HeartWare
2.2.1 HeartWare Details
2.2.2 HeartWare Major Business
2.2.3 HeartWare SWOT Analysis
2.2.4 HeartWare Product and Services
2.2.5 HeartWare Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Boston Scientific Corporation
2.5.1 Boston Scientific Corporation Details
2.5.2 Boston Scientific Corporation Major Business
2.5.3 Boston Scientific Corporation SWOT Analysis
2.5.4 Boston Scientific Corporation Product and Services
2.5.5 Boston Scientific Corporation Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Product and Services
2.6.4 Johnson & Johnson Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 GlaxoSmithKline plc
2.7.1 GlaxoSmithKline plc Details
2.7.2 GlaxoSmithKline plc Major Business
2.7.3 GlaxoSmithKline plc Product and Services
2.7.4 GlaxoSmithKline plc Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 New Haven Pharmaceuticals, Inc.
2.8.1 New Haven Pharmaceuticals, Inc. Details
2.8.2 New Haven Pharmaceuticals, Inc. Major Business
2.8.3 New Haven Pharmaceuticals, Inc. Product and Services
2.8.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Stanley Pharmaceuticals
2.9.1 Stanley Pharmaceuticals Details
2.9.2 Stanley Pharmaceuticals Major Business
2.9.3 Stanley Pharmaceuticals Product and Services
2.9.4 Stanley Pharmaceuticals Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Product and Services
2.10.4 Pfizer Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Symplmed Pharmaceuticals
2.11.1 Symplmed Pharmaceuticals Details
2.11.2 Symplmed Pharmaceuticals Major Business
2.11.3 Symplmed Pharmaceuticals Product and Services
2.11.4 Symplmed Pharmaceuticals Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Cardiokinetix
2.12.1 Cardiokinetix Details
2.12.2 Cardiokinetix Major Business
2.12.3 Cardiokinetix Product and Services
2.12.4 Cardiokinetix Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Novartis International AG
2.13.1 Novartis International AG Details
2.13.2 Novartis International AG Major Business
2.13.3 Novartis International AG Product and Services
2.13.4 Novartis International AG Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Jarvik Heart
2.14.1 Jarvik Heart Details
2.14.2 Jarvik Heart Major Business
2.14.3 Jarvik Heart Product and Services
2.14.4 Jarvik Heart Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Berlin Heart GmbH
2.15.1 Berlin Heart GmbH Details
2.15.2 Berlin Heart GmbH Major Business
2.15.3 Berlin Heart GmbH Product and Services
2.15.4 Berlin Heart GmbH Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Abiomed
2.16.1 Abiomed Details
2.16.2 Abiomed Major Business
2.16.3 Abiomed Product and Services
2.16.4 Abiomed Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Biovail Corporation
2.17.1 Biovail Corporation Details
2.17.2 Biovail Corporation Major Business
2.17.3 Biovail Corporation Product and Services
2.17.4 Biovail Corporation Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Biotronik
2.18.1 Biotronik Details
2.18.2 Biotronik Major Business
2.18.3 Biotronik Product and Services
2.18.3 Biotronik Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 ReliantHeart, Inc.
2.19.1 ReliantHeart, Inc. Details
2.19.2 ReliantHeart, Inc. Major Business
2.19.3 ReliantHeart, Inc. Product and Services
2.19.4 ReliantHeart, Inc. Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.20 Bristol-Myers Squibb Company
2.20.1 Bristol-Myers Squibb Company Details
2.20.2 Bristol-Myers Squibb Company Major Business
2.20.3 Bristol-Myers Squibb Company Product and Services
2.20.4 Bristol-Myers Squibb Company Chronic Heart Failure Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Chronic Heart Failure Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Chronic Heart Failure Treatment Players Market Share
3.2.2 Top 10 Chronic Heart Failure Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Chronic Heart Failure Treatment Revenue and Market Share by Regions
4.2 North America Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
5 North America Chronic Heart Failure Treatment Revenue by Countries
5.1 North America Chronic Heart Failure Treatment Revenue by Countries (2015-2020)
5.2 USA Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
6 Europe Chronic Heart Failure Treatment Revenue by Countries
6.1 Europe Chronic Heart Failure Treatment Revenue by Countries (2015-2020)
6.2 Germany Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
6.4 France Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Chronic Heart Failure Treatment Revenue by Countries
7.1 Asia-Pacific Chronic Heart Failure Treatment Revenue by Countries (2015-2020)
7.2 China Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
7.5 India Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
8 South America Chronic Heart Failure Treatment Revenue by Countries
8.1 South America Chronic Heart Failure Treatment Revenue by Countries (2015-2020)
8.2 Brazil Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Chronic Heart Failure Treatment by Countries
9.1 Middle East & Africa Chronic Heart Failure Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Chronic Heart Failure Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Chronic Heart Failure Treatment Market Forecast by Type (2019-2024)
10.3 ICDs Revenue Growth Rate (2015-2025)
10.4 VADs Revenue Growth Rate (2015-2025)
10.5 Drugs Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Chronic Heart Failure Treatment Market Segment by Application
11.1 Global Chronic Heart Failure Treatment Revenue Market Share by Application (2015-2020)
11.2 Chronic Heart Failure Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Household Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Chronic Heart Failure Treatment Market Size Forecast (2021-2025)
12.1 Global Chronic Heart Failure Treatment Market Size Forecast (2021-2025)
12.2 Global Chronic Heart Failure Treatment Market Forecast by Regions (2021-2025)
12.3 North America Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
12.6 South America Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Chronic Heart Failure Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Chronic Heart Failure Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Chronic Heart Failure Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Chronic Heart Failure Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Chronic Heart Failure Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Medtronic Corporate Information, Location and Competitors
Table 7. Medtronic Chronic Heart Failure Treatment Major Business
Table 8. Medtronic Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Medtronic SWOT Analysis
Table 10. Medtronic Chronic Heart Failure Treatment Product and Solutions
Table 11. Medtronic Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. HeartWare Corporate Information, Location and Competitors
Table 13. HeartWare Chronic Heart Failure Treatment Major Business
Table 14. HeartWare Chronic Heart Failure Treatment Total Revenue (USD Million) (2018-2019)
Table 15. HeartWare SWOT Analysis
Table 16. HeartWare Chronic Heart Failure Treatment Product and Solutions
Table 17. HeartWare Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Merck Corporate Information, Location and Competitors
Table 19. Merck Chronic Heart Failure Treatment Major Business
Table 20. Merck Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Merck SWOT Analysis
Table 22. Merck Chronic Heart Failure Treatment Product and Solutions
Table 23. Merck Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Abbott Corporate Information, Location and Competitors
Table 25. Abbott Chronic Heart Failure Treatment Major Business
Table 26. Abbott Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Abbott SWOT Analysis
Table 28. Abbott Chronic Heart Failure Treatment Product and Solutions
Table 29. Abbott Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Boston Scientific Corporation Corporate Information, Location and Competitors
Table 31. Boston Scientific Corporation Chronic Heart Failure Treatment Major Business
Table 32. Boston Scientific Corporation Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Boston Scientific Corporation SWOT Analysis
Table 34. Boston Scientific Corporation Chronic Heart Failure Treatment Product and Solutions
Table 35. Boston Scientific Corporation Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Johnson & Johnson Corporate Information, Location and Competitors
Table 37. Johnson & Johnson Chronic Heart Failure Treatment Major Business
Table 38. Johnson & Johnson Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Johnson & Johnson SWOT Analysis
Table 40. Johnson & Johnson Chronic Heart Failure Treatment Product and Solutions
Table 41. Johnson & Johnson Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. GlaxoSmithKline plc Corporate Information, Location and Competitors
Table 43. GlaxoSmithKline plc Chronic Heart Failure Treatment Major Business
Table 44. GlaxoSmithKline plc Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 45. GlaxoSmithKline plc SWOT Analysis
Table 46. GlaxoSmithKline plc Chronic Heart Failure Treatment Product and Solutions
Table 47. GlaxoSmithKline plc Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. New Haven Pharmaceuticals, Inc. Corporate Information, Location and Competitors
Table 49. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Major Business
Table 50. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 51. New Haven Pharmaceuticals, Inc. SWOT Analysis
Table 52. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Product and Solutions
Table 53. New Haven Pharmaceuticals, Inc. Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Stanley Pharmaceuticals Corporate Information, Location and Competitors
Table 55. Stanley Pharmaceuticals Chronic Heart Failure Treatment Major Business
Table 56. Stanley Pharmaceuticals Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 57. Stanley Pharmaceuticals SWOT Analysis
Table 58. Stanley Pharmaceuticals Chronic Heart Failure Treatment Product and Solutions
Table 59. Stanley Pharmaceuticals Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Pfizer Corporate Information, Location and Competitors
Table 61. Pfizer Chronic Heart Failure Treatment Major Business
Table 62. Pfizer Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 63. Pfizer SWOT Analysis
Table 64. Pfizer Chronic Heart Failure Treatment Product and Solutions
Table 65. Pfizer Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Symplmed Pharmaceuticals Corporate Information, Location and Competitors
Table 67. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Major Business
Table 68. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 69. Symplmed Pharmaceuticals SWOT Analysis
Table 70. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Product and Solutions
Table 71. Symplmed Pharmaceuticals Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Cardiokinetix Corporate Information, Location and Competitors
Table 73. Cardiokinetix Chronic Heart Failure Treatment Major Business
Table 74. Cardiokinetix Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 75. Cardiokinetix SWOT Analysis
Table 76. Cardiokinetix Chronic Heart Failure Treatment Product and Solutions
Table 77. Cardiokinetix Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Novartis International AG Corporate Information, Location and Competitors
Table 79. Novartis International AG Chronic Heart Failure Treatment Major Business
Table 80. Novartis International AG Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 81. Novartis International AG SWOT Analysis
Table 82. Novartis International AG Chronic Heart Failure Treatment Product and Solutions
Table 83. Novartis International AG Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Jarvik Heart Corporate Information, Location and Competitors
Table 85. Jarvik Heart Chronic Heart Failure Treatment Major Business
Table 86. Jarvik Heart Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 87. Jarvik Heart SWOT Analysis
Table 88. Jarvik Heart Chronic Heart Failure Treatment Product and Solutions
Table 89. Jarvik Heart Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Berlin Heart GmbH Corporate Information, Location and Competitors
Table 91. Berlin Heart GmbH Chronic Heart Failure Treatment Major Business
Table 92. Berlin Heart GmbH Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 93. Berlin Heart GmbH SWOT Analysis
Table 94. Berlin Heart GmbH Chronic Heart Failure Treatment Product and Solutions
Table 95. Berlin Heart GmbH Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Abiomed Corporate Information, Location and Competitors
Table 97. Abiomed Chronic Heart Failure Treatment Major Business
Table 98. Abiomed Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 99. Abiomed SWOT Analysis
Table 100. Abiomed Chronic Heart Failure Treatment Product and Solutions
Table 101. Abiomed Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Biovail Corporation Corporate Information, Location and Competitors
Table 103. Biovail Corporation Chronic Heart Failure Treatment Major Business
Table 104. Biovail Corporation Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 105. Biovail Corporation SWOT Analysis
Table 106. Biovail Corporation Chronic Heart Failure Treatment Product and Solutions
Table 107. Biovail Corporation Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Biotronik Chronic Heart Failure Treatment Type and Application
Table 109. Biotronik Chronic Heart Failure Treatment Major Business
Table 110. Biotronik Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 111. Biotronik SWOT Analysis
Table 112. Biotronik Chronic Heart Failure Treatment Product and Solutions
Table 113. Biotronik Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. ReliantHeart, Inc. Corporate Information, Location and Competitors
Table 115. ReliantHeart, Inc. Chronic Heart Failure Treatment Major Business
Table 116. ReliantHeart, Inc. Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 117. ReliantHeart, Inc. SWOT Analysis
Table 118. ReliantHeart, Inc. Chronic Heart Failure Treatment Product and Solutions
Table 119. ReliantHeart, Inc. Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 121. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Major Business
Table 122. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Total Revenue (USD Million) (2017-2018)
Table 123. Bristol-Myers Squibb Company SWOT Analysis
Table 124. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Product and Solutions
Table 125. Bristol-Myers Squibb Company Chronic Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Global Chronic Heart Failure Treatment Revenue (Million USD) by Players (2015-2020)
Table 127. Global Chronic Heart Failure Treatment Revenue Share by Players (2015-2020)
Table 128. Global Chronic Heart Failure Treatment Revenue (Million USD) by Regions (2015-2020)
Table 129. Global Chronic Heart Failure Treatment Revenue Market Share by Regions (2015-2020)
Table 130. North America Chronic Heart Failure Treatment Revenue by Countries (2015-2020)
Table 131. North America Chronic Heart Failure Treatment Revenue Market Share by Countries (2015-2020)
Table 132. Europe Chronic Heart Failure Treatment Revenue (Million USD) by Countries (2015-2020)
Table 133. Asia-Pacific Chronic Heart Failure Treatment Revenue (Million USD) by Countries (2015-2020)
Table 134. South America Chronic Heart Failure Treatment Revenue by Countries (2015-2020)
Table 135. South America Chronic Heart Failure Treatment Revenue Market Share by Countries (2015-2020)
Table 136. Middle East and Africa Chronic Heart Failure Treatment Revenue (Million USD) by Countries (2015-2020)
Table 137. Middle East and Africa Chronic Heart Failure Treatment Revenue Market Share by Countries (2015-2020)
Table 138. Global Chronic Heart Failure Treatment Revenue (Million USD) by Type (2015-2020)
Table 139. Global Chronic Heart Failure Treatment Revenue Share by Type (2015-2020)
Table 140. Global Chronic Heart Failure Treatment Revenue Forecast by Type (2021-2025)
Table 141. Global Chronic Heart Failure Treatment Revenue by Application (2015-2020)
Table 142. Global Chronic Heart Failure Treatment Revenue Share by Application (2015-2020)
Table 143. Global Chronic Heart Failure Treatment Revenue Forecast by Application (2021-2025)
Table 144. Global Chronic Heart Failure Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Chronic Heart Failure Treatment Picture
Figure 2. Global Chronic Heart Failure Treatment Revenue Market Share by Type in 2019
Figure 3. ICDs Picture
Figure 4. VADs Picture
Figure 5. Drugs Picture
Figure 6. Others Picture
Figure 7. Chronic Heart Failure Treatment Revenue Market Share by Application in 2019
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Household Picture
Figure 11. Others Picture
Figure 12. Global Chronic Heart Failure Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Chronic Heart Failure Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Chronic Heart Failure Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Chronic Heart Failure Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Chronic Heart Failure Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Chronic Heart Failure Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Chronic Heart Failure Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Chronic Heart Failure Treatment Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Chronic Heart Failure Treatment Revenue Market Share in 2019
Figure 21. Global Top 10 Players Chronic Heart Failure Treatment Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Chronic Heart Failure Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Chronic Heart Failure Treatment Revenue Market Share by Regions (2015-2020)
Figure 25. Global Chronic Heart Failure Treatment Revenue Market Share by Regions in 2018
Figure 26. North America Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Europe Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 29. South America Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 31. North America Chronic Heart Failure Treatment Revenue Market Share by Countries (2015-2020)
Figure 32. North America Chronic Heart Failure Treatment Revenue Market Share by Countries in 2019
Figure 33. USA Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Canada Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Europe Chronic Heart Failure Treatment Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Chronic Heart Failure Treatment Revenue Market Share by Countries in 2019
Figure 38. Germany Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 39. UK Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 40. France Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Russia Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Italy Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Chronic Heart Failure Treatment Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Chronic Heart Failure Treatment Revenue Market Share by Countries in 2019
Figure 45. China Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Japan Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Korea Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 48. India Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 50. South America Chronic Heart Failure Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. South America Chronic Heart Failure Treatment Revenue Market Share by Countries in 2019
Figure 52. Brazil Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Chronic Heart Failure Treatment Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Chronic Heart Failure Treatment Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 57. UAE Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Chronic Heart Failure Treatment Revenue and Growth Rate (2015-2020)
Figure 60. Global Chronic Heart Failure Treatment Revenue Share by Type (2015-2020)
Figure 61. Global Chronic Heart Failure Treatment Revenue Share by Type in 2019
Figure 62. Global Chronic Heart Failure Treatment Market Share Forecast by Type (2021-2025)
Figure 63. Global ICDs Revenue Growth Rate (2015-2020)
Figure 64. Global VADs Revenue Growth Rate (2015-2020)
Figure 65. Global Drugs Revenue Growth Rate (2015-2020)
Figure 66. Global Others Revenue Growth Rate (2015-2020)
Figure 67. Global Chronic Heart Failure Treatment Revenue Share by Application (2015-2020)
Figure 68. Global Chronic Heart Failure Treatment Revenue Share by Application in 2019
Figure 69. Global Chronic Heart Failure Treatment Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospital Revenue Growth Rate (2015-2020)
Figure 71. Global Clinic Revenue Growth Rate (2015-2020)
Figure 72. Global Household Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Chronic Heart Failure Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Chronic Heart Failure Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Chronic Heart Failure Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
Figure 78. Europe Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
Figure 80. South America Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Chronic Heart Failure Treatment Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
慢性心不全（CHF）治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Chronic Heart Failure (CHF) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…- 慢性心不全（CHF）装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Chronic Heart Failure (CHF) Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 高血圧及び心不全治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Hypertension and Heart Failure Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 慢性不応性咳嗽（CRC）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Chronic Refractory Cough (CRC) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …
- 慢性腰痛治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Chronic Low Back Pain Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chronic Low B…